Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle

US Patent 9850293 · Granted Dec 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Receptor targeting constructs and uses thereof2025
Method of making an aromagraph comprising ectopic olfactory receptors2025
In vitro induction of mammary-like differentiation from human pluripotent stem c2024
Targeted delivery system2023
Biosensor for detecting smell, scent, and taste2022
Receptor targeting constructs and uses thereof2022
Biosensor for detecting smell, scent, and taste2021
Ectopic olfactory receptors and uses thereof2021
Targeted delivery system2020
Isolating traffic-enhancing mutants of drug delivery protein2020
Generation of induced pluripotent stem cells from normal human mammary epithelia2020
Targeting corroles for tumor toxicity and MRI2020